Yidu Tech Launches 'Yidu ZhiXun' to Drive Intelligent, Evidence-Based Clinical Transformation

On March 10, Yidu Tech (2158.HK), a leading domestic AI healthcare enterprise, officially launched “Yidu Zhixun,” a clinical evidence-based intelligent agent—a mini-program designed as an “evidence-based assistant” specifically for physicians. Addressing the real-world needs of doctors in clinical diagnosis, treatment, and scientific research, it breaks down the cumbersome barriers traditionally associated with accessing medical knowledge. By freeing physicians from the burdens of extensive literature reviews and evidence appraisal, it enables rapid, efficient decision support in both clinical and research settings. This allows doctors to devote their valuable time to deepening professional expertise and enhancing capabilities, thereby driving the transformation of clinical practice models toward intelligence and evidence-based medicine.

“Yidu Zhixun” is now available for public use. During the one-week internal beta test, it attracted over 6,000 healthcare professionals to actively participate, yielding nearly 2,000 high-quality and valid feedback submissions. The product’s practicality and professionalism have been highly recognized within the industry. Many clinicians involved in the beta testing stated that “Yidu Zhixun” performed excellently in tasks such as rapidly accessing clinical guideline knowledge, obtaining treatment plans, querying drug interactions, assessing tumor staging, searching for clinical trials, and tracking cutting-edge advancements, significantly improving the efficiency of clinical information retrieval and enhancing physicians’ evidence-based decision support capabilities.

The true value of clinical-grade AI lies at its core in professionalism and trustworthiness.

“Yidu Zhixun” is built upon a rigorous evidence-based evaluation system, distilling a high-quality knowledge repository from vast medical resources: it carefully selects over 30,000 pieces of content from authoritative institutions out of more than 40,000 guidelines, and curates over 5 million high-quality research findings from more than 30 million publications. Furthermore, in collaboration with authoritative organizations such as the People’s Medical Publishing House, it has constructed disease and drug knowledge bases reviewed by clinical experts, ensuring that every piece of knowledge originates from professional sources.

More importantly, “Yidu Zhixun” is not a static knowledge base; it continuously tracks the latest research and findings from top-tier journals such as NEJM, The Lancet, and JAMA, enabling physicians to access cutting-edge medical evidence in real time and addressing the pain point of delayed updates inherent in traditional knowledge bases.

In clinical decision-making, physicians do not need a “black box” that merely provides conclusions; rather, they require a robust “dossier of evidence.” The core capability of “Yidu Zhixun” lies in fully transparentizing the AI’s generation process, transforming every recommendation into verifiable and assessable evidence-based support.

When physicians pose queries to “Yidu Zhixun,” the system does not simply retrieve a pre-existing answer; instead, it automatically executes a comprehensive process of evidence retrieval, graded assessment, and logical integration in the background. What is ultimately presented to the physician is a well-structured, rigorously annotated evidence-based response—

Every conclusion has a clear source.The system appends corresponding guidelines or literature references, enabling physicians to verify the original sources with a single click. This not only builds physicians’ trust in AI but also provides traceable evidence for medical quality and safety, clinical teaching, and discussions of complex cases.

Each answer is ranked by level of evidence.Leveraging evidence-based grading systems such as GRADE, the system automatically assesses the authority and timeliness of evidence. It strictly ranks answers by evidence level weight, eliminating the need for physicians to laboriously evaluate information quality, thereby making clinical decision-making more effortless and precise.

Clinical questions span multiple specialties and cover diverse scenarios, making it difficult for general-purpose AI to meet specialized needs. “Yidu Zhixun” incorporates a multi-specialty intelligent agent distribution engine that intelligently identifies the specialty attributes and clinical intent of each query, automatically routing it to the corresponding specialty-specific agent. Each agent is deeply trained on high-quality, domain-specific data, enabling “specialty-specific responses with precise adaptation,” thereby ensuring answers are more aligned with real-world clinical practice and more professional.

In addition to the general version, "Yidu Zhixun" also providesHospital Exclusive Version, it can deeply integrate with existing hospital information systems under strict adherence to data security and compliance requirements. By leveraging individual patient diagnostic and treatment data, it generates more targeted and personalized evidence-based recommendations, thereby achieving seamless integration of AI into clinical workflows and ensuring that intelligent empowerment is effectively implemented.

Currently, “Yidu Zhixun” has undergone in-depth clinical validation at hospitals such as the Sun Yat-sen University Cancer Center, covering 15 core cancer types including lung cancer, breast cancer, liver cancer, and colorectal cancer. The concordance rate between its recommended treatment plans and clinicians’ decisions is exceptionally high.

According to the company, the “Yidu Zhixun” app will also be launched in the near future, promising more features and a more comprehensive user experience.

In an era of information overload, the scarcest resource for physicians is not knowledge, but time. What “Yidu Zhixun” achieves is not merely shortening the distance between “questions” and “answers,” but also returning precious time to doctors. Looking ahead, Yidu Tech will continue to drive product evolution through technological innovation, making “Yidu Zhixun” a trusted intelligent companion for every clinical practitioner and empowering the advancement of healthcare with the power of intelligent evidence-based medicine.